Agilent Technologies, Inc. (A)

Basic

  • Market Cap

    $40.75B

  • EV

    $41.56B

  • Shares Out

    293.04M

  • Revenue

    $6,735M

  • Employees

    18,000

Margins

  • Gross

    50.56%

  • EBITDA

    24.2%

  • Operating

    20.25%

  • Pre-Tax

    19.78%

  • Net

    18.35%

  • FCF

    24.48%

Returns (5Yr Avg)

  • ROA

    8.17%

  • ROTA

    25.69%

  • ROE

    21.44%

  • ROCE

    15.75%

  • ROIC

    15.92%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $144.82

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,748M

  • Net Debt

    $807M

  • Debt/Equity

    0.41

  • EBIT/Interest

    14.83

Growth (CAGR)

  • Rev 3Yr

    6.79%

  • Rev 5Yr

    6.19%

  • Rev 10Yr

    0.98%

  • Dil EPS 3Yr

    17.17%

  • Dil EPS 5Yr

    3.54%

  • Dil EPS 10Yr

    7.91%

  • Rev Fwd 2Yr

    2.75%

  • EBITDA Fwd 2Yr

    5.83%

  • EPS Fwd 2Yr

    5.53%

  • EPS LT Growth Est

    6.3%

Dividends

  • Yield

  • Payout

    21.61%

  • DPS

    $0.91

  • DPS Growth 3Yr

    7.47%

  • DPS Growth 5Yr

    8.32%

  • DPS Growth 10Yr

    6.35%

  • DPS Growth Fwd 2Yr

    6.76%

Select a metric from the list below to chart it

Oct '14

Oct '15

Oct '16

Oct '17

Oct '18

Oct '19

Oct '20

Oct '21

Oct '22

Oct '23

LTM

Total Revenues

5,163

5,339

6,319

6,848

6,833

6,735

Total Revenues % Chg.

5.1%

3.4%

18.4%

8.4%

-0.2%

-2.8%

Cost of Goods Sold, Total

2,358

2,502

2,912

3,126

3,368

3,330

Gross Profit

2,805

2,837

3,407

3,722

3,465

3,405

Selling General & Admin Expenses, Total

1,358

1,395

1,562

1,578

1,578

1,555

R&D Expenses

404

397

441

467

481

486

Other Operating Expenses, Total

1,762

1,792

2,003

2,045

2,059

2,041

Operating Income

1,043

1,045

1,404

1,677

1,406

1,364

Interest Expense, Total

-74

-78

-81

-84

-95

-92

Interest And Investment Income

36

8

2

9

51

60

Net Interest Expenses

-38

-70

-79

-75

-44

-32

Income (Loss) On Equity Invest.

Currency Exchange Gains (Loss)

-7

-4

-4

-6

-2

-2

Other Non Operating Income (Expenses)

18

14

15

14

62

85

EBT, Excl. Unusual Items

1,016

985

1,336

1,610

1,422

1,415

Restructuring Charges

-44

-151

-37

-30

-25

-25

Merger & Related Restructuring Charges

-48

-41

-41

-25

-16

-16

Gain (Loss) On Sale Of Investments

4

27

98

-67

-41

-41

Asset Writedown

Legal Settlements

22

Other Unusual Items

-9

4

16

-1

-1

EBT, Incl. Unusual Items

919

842

1,360

1,504

1,339

1,332

Income Tax Expense

-152

123

150

250

99

96

Earnings From Continuing Operations

1,071

719

1,210

1,254

1,240

1,236

Earnings Of Discontinued Operations

Net Income

1,071

719

1,210

1,254

1,240

1,236

Net Income to Common Incl Extra Items

1,071

719

1,210

1,254

1,240

1,236

Net Income to Common Excl. Extra Items

1,071

719

1,210

1,254

1,240

1,236

Total Shares Outstanding

309.1

306.2

302.2

295.3

292.1

293

Weighted Avg. Shares Outstanding

314

309

304

299

294

293.3

Weighted Avg. Shares Outstanding Dil

318

312

307

300

296

295.3

EPS

3.4

2.3

4

4.2

4.2

4.2

EPS Diluted

3.4

2.3

3.9

4.2

4.2

4.2

EBITDA

1,281

1,353

1,725

1,994

1,677

1,630